ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare,

What was recalled

The U.S. Food and Drug Administration (FDA) has issued a Class II recall involving a specific batch of prescription thyroid medication manufactured by Accord Healthcare, Inc. This action centers on Levothyroxine Sodium Tablets, USP, specifically those with a strength of 50 mcg (which is equivalent to 0.05 mg). These are not over-the-counter supplements; they are Rx-only medications prescribed to help regulate the body’s thyroid hormone levels. The recall applies exclusively to 1,000-count bottles of this medication. It is important to note that Accord Healthcare, Inc., based in Raleigh, North Carolina, is the entity for whom the product was manufactured, while the actual production took place at Intas Pharmaceuticals Limited in Selaqui, Dehradun, India.

The scope of this recall is defined by precise National Drug Code (NDC) numbers and lot identifiers. The affected product carries the NDC 16729-448-17. However, not every bottle with this code is necessarily part of the problem; the issue is tied to specific manufacturing lots. Consumers must check their bottles for the following lot numbers: D2401834 and D2401982, which have an expiration date of August 31, 2026. Additionally, another group of lots includes D2402584, D2402585, D2402586, D2402588, D2402587, and D2402589, all of which are set to expire on November 30, 2026. If your bottle does not match these exact lot numbers, it is likely not part of this specific recall event.

This medication was distributed nationwide across the United States, meaning it could be found in pharmacies and healthcare settings in any state. The recall was initiated on August 6, 2026. While the distribution pattern indicates a broad geographic reach, the classification as a Class II recall suggests that the use of this product may cause temporary health problems or pose only a slight threat of a serious nature, though it is unlikely to cause death. The decision to recall these specific units was driven by the determination that the drug is subpotent, meaning it does not contain the amount of active ingredient declared on the label. This discrepancy affects the reliability of the dosage patients depend on for their treatment.

To identify if you have been affected, you need to physically inspect your prescription bottle. Look closely at the label for the NDC number and the lot number stamped or printed on the packaging. The brand associated with this recall is Accord Healthcare. If you possess a 1,000-count bottle of Levothyroxine Sodium Tablets, USP, 50 mcg, manufactured for Accord Healthcare, Inc., and your lot number matches one of the eight listed above, you are holding a product that is subject to this FDA recall action.

The hazard, explained

When the Food and Drug Administration flags a drug as "subpotent," it is describing a very specific kind of chemical failure: the medication contains less active ingredient than it claims on the label. In plain terms, this means the pills are weaker than they should be. For most medicines, taking a slightly lower dose might just mean the treatment works a bit slower. But for levothyroxine sodium—a synthetic version of the thyroid hormone thyroxine (T4)—the margin for error is incredibly thin. Your body relies on precise levels of this hormone to regulate your metabolism, heart rate, body temperature, and energy production. When the drug is subpotent, your thyroid hormone levels in the blood drop below the therapeutic range, a condition known as hypothyroxinemia.

The physical reason for this failure usually lies in the manufacturing process. Levothyroxine is a delicate compound that can be sensitive to environmental factors during production, such as humidity, temperature control, or mixing consistency. In this specific recall by Accord Healthcare, Inc., the issue affects bottles manufactured by Intas Pharmaceuticals Limited in India. While the exact chemical reason for the subpotency isn't detailed in the public record, it often happens when the concentration of the active pharmaceutical ingredient does not meet the strict standards required to deliver the labeled dose of 50 mcg (0.05 mg). As a result, patients who take these tablets are effectively receiving less medication than prescribed. If your doctor prescribed 100 mcg by giving you two of these pills, you might only be getting the equivalent of 80 or 90 mcg, depending on how far off the potency is.

This creates a silent but significant health risk because levothyroxine treats an underlying condition that is often invisible until it becomes severe. Hypothyroidism means your body’s engine is running too slowly. If you continue taking subpotent medication, you are not just "under-treated"; you are actively allowing your thyroid function to deteriorate. Over time, this can lead to a cascade of physiological problems. You might experience worsening fatigue, unexplained weight gain, sensitivity to cold, and cognitive issues like brain fog or memory lapses. More seriously, prolonged untreated hypothyroidism can raise cholesterol levels, leading to heart disease, and in extreme cases, can affect the heart muscle itself.

The danger is compounded by the fact that these symptoms develop gradually. You might attribute your increasing tiredness to aging or stress, not realizing that your medication has stopped working correctly. Because levothyroxine has a long half-life (it stays in your body for about a week), the effects of subpotency don't appear overnight. It takes weeks or months for hormone levels to drop enough to cause noticeable clinical symptoms. This delay can make it difficult to connect the problem back to the specific batch of pills you were taking, which is why regulatory alerts like this are critical for public health.

Who is most at risk

When a medication like Levothyroxine Sodium is recalled for being subpotent, the people most immediately at risk are those who rely on this specific drug to manage their thyroid health. This is not a general wellness supplement; it is a prescription-only hormone replacement therapy used by individuals whose bodies do not produce enough thyroid hormone naturally. For these patients, the medication is not optional—it is a critical component of their daily physiological balance. The primary group at risk consists of adults currently taking the recalled Accord Healthcare product: Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), specifically those who possess bottles containing the lot numbers D2401834, D2401982, D2402584, D2402585, D2402586, D2402588, D2402587, or D2402589.

The vulnerability in this situation stems from the nature of thyroid hormone itself. Thyroid hormones regulate metabolism, heart rate, body temperature, and energy levels. Because the therapeutic window for levothyroxine is narrow, even a small deviation in dosage can lead to significant health consequences. A "subpotent" drug means that the tablets contain less active ingredient than what is stated on the label. If a patient is prescribed 50 mcg but receives a tablet with only 40 mcg or 45 mcg due to manufacturing errors, their body is effectively receiving an underdose. Over time, this cumulative deficit can cause thyroid hormone levels in the blood to drop below the necessary threshold, leading to a state of hypothyroidism.

While any patient on this medication is at risk for losing therapeutic control, certain demographics may experience more severe or rapid symptoms when their dosage is compromised. Older adults are often particularly vulnerable because they may have pre-existing cardiovascular conditions. Thyroid hormone directly affects the heart; insufficient levels can lead to a slowed heart rate (bradycardia), increased cholesterol levels, and fluid retention, which can put additional strain on an aging heart. For elderly patients who may already be managing multiple health issues, the sudden onset of these symptoms can be confusing and dangerous, potentially leading to misdiagnosis or delayed treatment.

Pregnant individuals are also in a high-risk category if they are taking this medication. Thyroid hormone is essential for fetal brain development, especially during the first trimester. Even mild hypothyroidism during pregnancy can impact cognitive development in the baby. Therefore, any woman of childbearing age who is pregnant or planning to become pregnant and is using this specific lot of Accord Healthcare’s Levothyroxine must be especially cautious. The lack of a stated remedy in the official recall notice heightens this concern, as it implies that patients must proactively seek alternative sources of their medication immediately rather than waiting for a replacement from the manufacturer.

Additionally, individuals with severe pre-existing hypothyroidism or those who have undergone thyroid removal surgery are dependent on precise exogenous hormone levels. Their bodies have no reserve capacity to correct the imbalance. For these patients, the "subpotent" nature of the recalled drug could lead to a rapid return of symptoms such as extreme fatigue, weight gain, depression, and cold intolerance. It is crucial to recognize that the risk is not just about feeling tired; it is about maintaining the metabolic stability required for daily organ function. Therefore, anyone who has filled a prescription for this specific Accord Healthcare product between its distribution date and the recall announcement on August 6, 2026, should consider themselves potentially affected until they can verify their lot number or obtain medical advice.

How to tell if you have the recalled item

• Lot D2401834 or D2401982 with an expiration date of 08/31/2026.
• Lot D2402584, D2402585, D2402586, D2402587, D2402588, or D2402589 with an expiration date of 11/30/2026.

What to do — step by step

If you currently have a bottle of Accord Healthcare’s Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg) in your medicine cabinet, it is important to handle the situation with care and precision. Because the FDA has classified this as a Class II recall due to the drug being subpotent—meaning it may not contain the full amount of active ingredient listed on the label—your immediate actions should focus on safety, verification, and professional guidance. The official remedy for this specific recall was not explicitly stated in the FDA’s announcement, which means you cannot rely on a simple mail-in return or automatic replacement from the manufacturer without further instruction. Instead, your path forward involves a careful, step-by-step process to ensure you do not inadvertently compromise your health.

Step 1: Do Not Stop Taking Your Medication Abruptly
Levothyroxine is a hormone replacement therapy used to treat an underactive thyroid (hypothyroidism). Unlike some medications that can be stopped suddenly without consequence, thyroid medication often requires consistent levels in your bloodstream. Stopping it cold turkey can lead to a return of symptoms such as fatigue, weight gain, and depression, or worse, a dangerous condition called myxedema. Therefore, before you take any action regarding the recalled stock, you must contact your prescribing physician or pharmacist immediately. Explain that you have this specific lot number and ask for their advice on how to transition to a non-recalled supply. They may provide a new prescription from a different manufacturer or batch to ensure there is no gap in your treatment.

Step 2: Verify Your Bottle Against the Recall Details
You need to confirm whether your specific bottle is part of this recall. Check the label on your bottle for the following details:

• Brand: Accord Healthcare, Inc.
• NDC Number: 16729-448-17
• Lot Numbers: D2401834, D2401982, D2402584, D2402585, D2402586, D2402588, D2402587, or D2402589
• Expiration Dates: 08/31/2026 or 11/30/2026

If your bottle matches these lot numbers and expiration dates, it is part of the recall. If the lot number does not appear in this list, your medication is likely safe to continue using as prescribed, but you should still keep this information handy in case the recall expands.

Step 3: Contact Your Pharmacy or Manufacturer
Since a specific return address or refund process was not provided by the FDA for this recall, your local pharmacy is your best first point of contact. They can often help you identify alternative stock that is not affected by the subpotency issue. If you purchased the medication directly from Accord Healthcare or through a mail-order service, you should also contact their customer service department. Provide them with your lot number and ask if they are initiating any voluntary return or credit program. Keep records of all communications, including dates, names of representatives, and any case numbers provided.

Step 4: Monitor Your Health
While you arrange for a replacement supply, pay close attention to your body. Because the recalled tablets are subpotent, they may not be effectively treating your hypothyroidism. Watch for symptoms such as increased fatigue, cold sensitivity, constipation, dry skin, or hair loss. If you experience severe symptoms, contact your healthcare provider right away. They may order blood tests to check your thyroid-stimulating hormone (TSH) levels and adjust your dosage temporarily until you can switch to a verified, non-recalled medication.

Your refund, repair, or replacement options

One of the most pressing questions when you hear about a drug recall is exactly what happens next with your money and your medication. In this specific case involving Accord Healthcare’s Levothyroxine Sodium Tablets, the official FDA recall documentation does not explicitly state a standard remedy such as a direct refund, a prepaid return label, or a guaranteed replacement unit. This absence of a stated remedy in the public notice is important to understand: it does not mean you are left without recourse, but rather that the process may require a bit more proactive navigation on your part compared to recalls where a “return for credit” program is clearly advertised.

Because Levothyroxine is a prescription medication used to treat hypothyroidism—a condition where the thyroid gland does not produce enough thyroid hormone—your immediate priority should be continuity of care rather than just financial restitution. Subpotent drugs contain less of the active ingredient than labeled, which can lead to ineffective treatment. Therefore, before worrying about refunds, you must consult your prescribing physician or pharmacist. They are the key stakeholders here. Your doctor can issue a new prescription for a different lot number or potentially a different manufacturer’s version of the drug that is not part of this recall. This ensures that your thyroid levels remain stable and that you do not experience health complications due to interrupted or ineffective treatment.

Regarding the financial aspect, the remedy typically involves working through the point of purchase. Since these 1000-count bottles were distributed nationwide, you likely obtained them through a specific pharmacy chain or mail-order service. You should contact that pharmacy directly. Even though the FDA notice does not list a specific customer service number for Accord Healthcare, pharmacies have their own supplier return protocols. They will know how to handle the defective stock from their wholesaler. In most cases, if you return the unopened or partially opened recalled bottles, the pharmacy will credit your account or provide a store credit for the cost of the medication. This is generally considered the standard industry practice for drug recalls involving subpotent products, even when not explicitly detailed in the government alert.

If you purchased these tablets from a physical retail location rather than a specialized pharmacy, bring the bottles and your receipt to the customer service desk. The store will typically process a refund or exchange according to their specific return policy for pharmaceuticals. It is crucial to keep all packaging and lot numbers handy, as staff may need to verify that you are returning the specific recalled items (Lot #s D2401834, D2401982, Exp. 08/31/2026; or D2402584 through D2402589, Exp. 11/30/2026) to ensure the correct compensation is issued.

• Contact your pharmacist first: They can help coordinate the supply of non-recalled medication and guide you on the return process.
• Do not discard the medication yet: Keep the bottles in a safe place until you have spoken to your pharmacy or doctor.
• Check your receipt: Having proof of purchase will streamline any potential refund or credit process at the point of sale.

What can happen if you ignore it

Staying safe: broader tips

When you think about medication safety, it is easy to focus entirely on the specific pill in your hand right now. However, true safety comes from building a reliable system around how you manage your health supplies over time. One of the most effective ways to protect yourself is by establishing a routine for monitoring official recalls. The U.S. Food and Drug Administration (FDA) and other regulatory bodies issue these alerts when potential issues are identified, but they do not always reach every patient directly. You can stay ahead of these notifications by signing up for email alerts on the FDA’s website or using reputable health news aggregators. This proactive approach ensures that you are informed before a problem affects your daily routine, allowing you to act calmly and quickly rather than reacting in panic.

Another critical habit is maintaining an organized inventory of your medications. This does not mean you need to be a pharmacist, but keeping a simple list or digital record of what you have, including lot numbers and expiration dates, can be invaluable. When a recall is announced, having this information readily available allows you to verify whether your specific bottles are affected in seconds. It also helps you manage your supply chain more effectively. For chronic conditions like thyroid disorders, which require consistent medication levels, it is wise to discuss backup plans with your healthcare provider before you ever need them. Knowing who to call and where to go if your current supply is recalled prevents dangerous gaps in treatment.

Finally, always practice proper storage and handling of pharmaceuticals. Many drug integrity issues stem from environmental factors rather than manufacturing defects. Keep your medications in a cool, dry place away from direct sunlight and humidity, which can degrade active ingredients over time. Avoid storing them in bathrooms or near kitchens where temperature and moisture fluctuate rapidly. Check expiration dates regularly and dispose of old medications according to local guidelines. By combining vigilance with good organizational habits, you create a buffer against the unexpected, ensuring that your health remains stable regardless of supply chain disruptions.

• Subscribe to FDA recall alerts for personalized notifications.
• Keep a digital or physical log of your medication lot numbers.
• Store medicines in stable, dry environments away from heat sources.